Pancreatic Cancer Research

ResearcherUniversity of Florida HealthNo recent work listed

Michael H. Gerber

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5283-7417; OpenAlex author ID A5053502606. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2017: 3 papers · 2018: 3 papers · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 11

  1. Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. Co-author DOI 10.1371/journal.pone.0281182↗
  2. The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neo.2022.100789↗
  3. Protein Signatures and Tissue Diagnosis of Pancreatic Cancer. First author DOI 10.1016/j.jamcollsurg.2019.10.002↗
  4. Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia. Co-author DOI 10.3390/cancers12020329↗
  5. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) mode… Co-author DOI 10.1007/s10637-018-0647-0↗
  6. Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival. Co-author DOI 10.1093/jncics/pky043↗
  7. Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.23532↗
  8. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine. Co-author DOI 10.3390/ijms19123836↗
  9. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Huma… Co-author DOI 10.1097/mpa.0000000000000843↗
  10. Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Co-author DOI 10.1158/0008-5472.can-16-1765↗
  11. Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia. Co-author DOI 10.18632/oncotarget.13593↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jose Gilberto Trevino · 9 shared papers, 2017–2023 · strength 0.83
  2. Steven J. Hughes · 8 shared papers, 2017–2022 · strength 0.68
  3. Patrick W. Underwood · 5 shared papers, 2018–2023 · strength 0.59
  4. Daniel Delitto · 7 shared papers, 2017–2020 · strength 0.56
  5. Song Han · 5 shared papers, 2017–2022 · strength 0.48
  6. Sarah M. Judge · 5 shared papers, 2017–2020 · strength 0.39
  7. Andrew R. Judge · 5 shared papers, 2017–2020 · strength 0.39
  8. Kelly M. Herremans · 2 shared papers, 2022–2023 · strength 0.30
  9. Andrea N. Riner · 2 shared papers, 2022–2023 · strength 0.30
  10. Ryan Michael Thomas · 3 shared papers, 2017–2020 · strength 0.24
  11. Miles E. Cameron · 2 shared papers, 2018–2020 · strength 0.19
  12. Christopher E Forsmark · 2 shared papers, 2018–2020 · strength 0.19
  13. Shannon Margaret Wallet · 3 shared papers, 2017–2018 · strength 0.19
  14. K.E. Behrns · 3 shared papers, 2017 · strength 0.19
  15. Thomas J. George · 3 shared papers, 2017 · strength 0.19
  16. V. Ashutosh Rao · 1 shared paper, 2023 · strength 0.17
  17. Thomas G. Biel · 1 shared paper, 2023 · strength 0.17
  18. Riley P. Bohan · 1 shared paper, 2022 · strength 0.14
  19. Gerik W. Tushoski-Alemán · 1 shared paper, 2022 · strength 0.14
  20. Hendrik Luesch · 1 shared paper, 2019 · strength 0.10
  21. Weijing Cai · 1 shared paper, 2019 · strength 0.10
  22. Jennifer B. Permuth · 1 shared paper, 2018 · strength 0.07
  23. Kristina L. Go · 1 shared paper, 2017 · strength 0.07
  24. Kien Pham · 1 shared paper, 2017 · strength 0.05
  25. Chen Liu · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.